Exploration of Potential Prodrugs of RWJ‐445167, an Oxyguanidine‐based Dual Inhibitor of Thrombin and Factor Xa
- 1 July 2006
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 68 (1), 29-36
- https://doi.org/10.1111/j.1747-0285.2006.00408.x
Abstract
Compound 2 (RWJ-445167; 3DP-10017), a dual inhibitor of thrombin and factor Xa, was advanced into human clinical studies. However, its oral bioavailability in humans proved to be below acceptable limits. To address this issue, we explored a prodrug approach involving numerous guanidine derivatives. Prodrug candidates of classes A (carbamate derivatives), B (imidate derivatives), and C (alkyl and acyl derivatives), compounds 3-6, were synthesized and evaluated for anticoagulant activity at 2 h after oral administration to rats. In comparison to the parent drug (2), little worthwhile improvement was observed for the prodrug candidates.Keywords
This publication has 39 references indexed in Scilit:
- Factor Xa inhibitors: new anti-thrombotic agents and their characteristicsFrontiers in Bioscience-Landmark, 2006
- New anticoagulants: beyond heparin, low‐molecular‐weight heparin and warfarinBritish Journal of Pharmacology, 2005
- Thrombin-directed inhibitors: Pharmacology and clinical useAmerican Heart Journal, 2005
- Dabigatran/Dabigatran etexilateDrugs of the Future, 2005
- In-Depth Study of Tripeptide-Based α-Ketoheterocycles as Inhibitors of Thrombin. Effective Utilization of the S1‘ Subsite and Its Implications to Structure-Based Drug DesignJournal of Medicinal Chemistry, 2004
- Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesisBioorganic & Medicinal Chemistry Letters, 2004
- Novel thrombin inhibitors that are based on a macrocyclic tripeptide motifBioorganic & Medicinal Chemistry Letters, 1996
- Prodrug forms for the sulfonamide group. III. Chemical and enzymatic hydrolysis of various N-sulfonyl imidates—a novel prodrug form for a sulfonamide group or an ester functionInternational Journal of Pharmaceutics, 1989
- N-Sulfonyl imidates as a novel prodrug form for an ester function or a sulfonamide groupJournal of Medicinal Chemistry, 1988
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973